Cetera Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $593K | Buy |
6,785
+4,324
| +176% | +$378K | ﹤0.01% | 1497 |
|
|
2023
Q4 | $237K | Buy |
+2,461
| New | +$237K | ﹤0.01% | 1555 |
|
|
2023
Q2 | – | Sell |
-2,469
| Closed | -$240K | – | 1657 |
|
|
2023
Q1 | $240K | Sell |
2,469
-13,131
| -84% | -$1.28M | ﹤0.01% | 1402 |
|
|
2022
Q4 | $1.61M | Buy |
15,600
+4,166
| +36% | +$431K | 0.03% | 508 |
|
|
2022
Q3 | $969K | Buy |
11,434
+4,682
| +69% | +$397K | 0.03% | 548 |
|
|
2022
Q2 | $560K | Buy |
+6,752
| New | +$560K | 0.01% | 790 |
|